Emory University Acadia Pharmaceuticals Inc Transaction History

Emory University

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2019 Nov 14, 2019	SELL	$22.22 - $44.01 $2 Million - $3.97 Million	-90,188 Closed	0 $0
Q2 2019 Aug 14, 2019	SELL	$23.32 - $28.12 $289,121 - $348,631	-12,398 Reduced 12.09%	90,188 $2.41 Million
Q1 2019 May 09, 2019	SELL	$16.17 - $27.38 $323,868 - $548,394	-20,029 Reduced 16.33%	102,586 $2.75 Million
Q4 2018 Feb 12, 2019	BUY	$14.32 - $22.92 $1.76 Million - $2.81 Million	122,615 New	122,615 $1.98 Million

280

156M

901K

314K

Ticker ACAD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 161,843,008
Market Cap $2.68B
Description
ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of small molecule drugs that address unmet medical needs in central nervous system disorders. The company offers NUPLAZID (pimavanserin) for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis. It's p...

Get notified when there are updates to the investment portfolio of Emory University, based on Form 13F filings with the SEC.

Stay updated on Emory University with notifications on news.